Business ❯ Pharmaceuticals

Drug Manufacturers

Pricing Strategies Eli Lilly Pricing Agreements Novo Nordisk Negotiations Mallinckrodt Pharmaceuticals Market Agreements Kenvue Market Dynamics Market Competition Covid-19 Treatments GLP-1 Drugs EMD Serono Generic Drugs Cipla Market Impact Catalent Discounts Corporate Leadership Major Companies Cost Reduction Initiatives Negotiation Strategies

DEA Drug Take Back Day Runs Nationwide 10 A.M.–2 P.M.

The one-day push seeks to clear home medicine cabinets to reduce youth access to addictive pills.

CMS Unveils Voluntary BALANCE Program to Lower GLP-1 Costs for Medicare and Medicaid

White House Adds 9 Pharma Deals, Extending Drug-Price Pacts to 14 Manufacturers

White House Secures Nine More Drugmaker Pacts on MFN Pricing as TrumpRx Nears Launch

Medicare’s First Negotiated Drug Prices Take Effect Jan. 1, Cutting 2026 Costs

Medicare Sets 2027 Prices for 15 High-Cost Drugs, Including Ozempic

Lilly, Novo Nordisk Reject Mangoceuticals’ Claimed GLP-1 Partnership as Shares Sink

White House Clinches GLP-1 Price Deal as Lilly Sets Zepbound and Pill Pricing

Kenvue Urges HHS to Reject Autism Link to Prenatal Tylenol in Private Meeting